Search Result "nonHodgkin Lymphoma."
Recent Advances in Nanobiotechnology for the Treatment ofNon-Hodgkinâs Lymphoma
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 24 Issue: 9 Year: 2024 Page: 895-907
Author(s):
Role of MicroRNAs in B Cell Leukemias and Lymphomas
Journal: Current Molecular Medicine
Volume: 14 Issue: 5 Year: 2014 Page: 580-597
Author(s): A. Schmidt,R. Kuppers
TP73, An Under-Appreciated Player in Non-Hodgkin Lymphoma Pathogenesis and Management
Journal: Current Molecular Medicine
Volume: 14 Issue: 4 Year: 2014 Page: 432-439
Author(s): H.M. Hassan,B.J. Dave,R.K. Singh
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor forTreating Relapsed or Refractory Mantle Cell Lymphoma in Adults
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 30 Year: 2024 Page: 4757-4762
Author(s): Surya K. De
Chimeric Antigen Receptor-Engineered T-Cells - A New Way and Era for Lymphoma Treatment
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 14 Issue: 4 Year: 2019 Page: 312-323
Author(s): Romeo G. MihÄilÄ
Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 7 Year: 2012 Page: 829-834
Author(s): Yoshihiro Yakushijin,Tomiko Tatsukawa,Takumi Yamaguchi,Takashi Egawa,Noriaki Hidaka,Keiko Ido,Katsuya Suemaru,Masaki Yasukawa,Hiroak Araki
The Nuclear Orphan Receptor NR4A1 and NR4A3 as Tumor Suppressors in Hematologic Neoplasms
Journal: Current Drug Targets
Volume: 16 Issue: 1 Year: 2015 Page: 38-46
Author(s): Kerstin Wenzl,Katharina Troppan,Peter Neumeister,Alexander J.A. Deutsch
Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 65-69
Author(s): Kathy J. Helzlsouer,Lisa Gallicchio
Pediatric Hematological Malignancies â Clinical Manifestation, Treatment and Follow-Up
Ebook: Frontiers in Clinical Drug Research: Hematology
Volume: 3 Year: 2018
Author(s): Naga Ramya Lanka,Krishna Kanth Pulicherla
Doi: 10.2174/9781681083674118030006
Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Journal: Current Drug Therapy
Volume: 7 Issue: 4 Year: 2012 Page: 281-289
Author(s): Ravindra R. Chuda,Prakash Vishnu,David Aboulafia